Skip to main content
ECS Restore

ATHLETE 001 · EXPLORATORY N-OF-1

A longitudinal phenotype of adaptation.

Male, 41 · recreational endurance athlete · longitudinal self-observation

Chronology

A longitudinal observation, not a before-and-after claim.

  1. 01

    Baseline

    Initial longitudinal observations and estimated functional capacity.

  2. 02

    Biological remodelling period

    Whole-blood fatty-acid composition measured over time.

  3. 03

    Training introduction

    Structured aerobic training added as one changing exposure.

  4. 04

    Adaptation period

    Repeated physiological observations accumulated alongside changing context.

  5. 05

    Laboratory confirmation

    VO₂peak measured at 62.7 ml·kg⁻¹·min⁻¹.

Evidence status

measured

Directly observed physiological data.

derived

Calculated from measured signals.

exploratory inference

A proposed biological interpretation requiring validation.

hypothesis

A causal or mechanistic explanation to be tested.

Biological context

Biological substrate state changed over time.

Whole-blood fatty-acid composition was measured longitudinally as one marker of changing substrate environment.

Read the fatty-acid remodelling white paper →

AA:EPA ratio

Whole-blood composition · longitudinal observation

measured
4.26
Jun 25
3.83
Nov 25
4.07
Feb 26
2.61
Jun 26

Autonomic physiology

Measured signals and exploratory constructs are not equivalent.

This case distinguishes directly observed sleep-stage physiology from derived constructs. The current record supports N2 RMSSD values; it does not add unsupplied RHR or waking RMSSD values.

N2 RMSSD

Sleep-stage autonomic observation

measured
Nov
Dec
Jan
Feb
Mar
Apr
May
derived

Sleep Autonomic Gain: a proposed state-response construct.

exploratory inference

CB1 Availability Index: an exploratory interpretation, not direct measurement.

Metabolic phenotype

High fat oxidation persisted at high internal intensity.

During a 79-minute controlled running test, fat oxidation remained around ~1.0 g/min while heart rate approached ~95–99% of provisional LT2 HR.

Controlled running test · 79 minutes

~1.0 g/min fat oxidation maintained near provisional LT2 HR

measured
Start~30 min79 minHeart rate ↑Fat oxidation ~1.0 g/minLactate 3.4 → 3.5 mmol/L5.7 mmol/L at endProvisional LT2 HR

Observation. Fat oxidation remained high as intensity approached LT2.

Interpretation. This describes a distinctive phenotype; it does not establish mechanism or how it developed.

Functional capacity

Estimates and laboratory measurements are different evidence classes.

Wearable-derived estimates can provide longitudinal context. The laboratory value is reported separately as the confirmed measurement.

VO₂peak trajectory

Estimated trajectory and laboratory confirmation

measured
41
Dec 25
41
3 Apr 26
63
1 Jun 26
62.7
Jun–Jul 26
Estimated / wearable-derivedLaboratory-confirmed: 62.7 ml·kg⁻¹·min⁻¹

Synthesis

Temporal convergence, not evidence of causality.

The diagram orders co-occurring domains to make the case legible. It does not indicate direction, mechanism or contribution.

01

Substrate state

02

Recovery / autonomic physiology

03

Metabolic phenotype

04

Functional capacity

Evidence boundary

What this case cannot tell us.

Training, nutrition, substrate status and intervention exposure changed during the observation period. Multiple physiological outcomes also changed. This case cannot determine the contribution of any one factor, or combination of factors, to the observed phenotype.

Its value is hypothesis generation: identifying measurable relationships worth testing prospectively.

Prospective validation

From Athlete 001 to prospective testing.

A future study should turn a useful observational case into a defined, testable protocol.

  • 01Controlled baseline
  • 02Predefined intervention
  • 03Predefined training load
  • 04Fatty-acid measures
  • 05Sleep / autonomic measures
  • 06Metabolic testing
  • 07VO₂, lactate and substrate utilisation
  • 08Predefined endpoints